As part of its plan to transfer the advanced features on its high-end Accuvix ultrasound product to midrange systems, Medison USA introduced the SonoAce X4 at the 2006 RSNA meeting.
As part of its plan to transfer the advanced features on its high-end Accuvix ultrasound product to midrange systems, Medison USA introduced the SonoAce X4 at the 2006 RSNA meeting.
SonoAce X4 is a full-featured gray-scale Doppler system sporting several premium imaging technologies but bearing a moderate price tag. The X4 is capable of high-resolution 2D imaging, with full-spectrum imaging powered by frequency compounding, as well as tissue harmonic imaging, spectral Doppler, and a high dynamic (150dB) range. The unit also features freehand 3D, multiplanar imaging, Quick Scan automatic optimization, post-gain control, and high-resolution zoom.
Developed primarily for ob-gyn practices, the lightweight, slim design offers a simplified backlit console with a wide selection of transducers, including convex, endocavity, linear, and microconvex probes.
"All of that technology is in a very small footprint, and that's what many ob-gyn physicians in the office are looking for," said Dennis Wisher, director of education and product management. "Many offices don't have the space for a large system, so they need a system that can fit in to their existing exam room. In the past when they've gone to a smaller system, they've had to accept much less in resolution and features. With the X4, we've placed a tremendous amount of the technology from our higher end systems into a smaller, cost-effective machine."
All of Medison's ultrasound systems have digital beam-forming technology to assure high-quality images.
"This is because, no matter what market you're in, the main focus is still on resolution," Wisher said. "You want to make sure you have the best resolution in a system that you can afford."
FDA Clears AI-Powered Ultrasound Software for Cardiac Amyloidosis Detection
November 20th 2024The AI-enabled EchoGo® Amyloidosis software for echocardiography has reportedly demonstrated an 84.5 percent sensitivity rate for diagnosing cardiac amyloidosis in heart failure patients 65 years of age and older.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.